Actinogen Medical LimitedASX: ACW

ACW XanaMIA Alzheimers open label trial commences

Apr 1, 2026 at 2:20 AM UTC · Issued by Actinogen Medical Limited

Actinogen Medical Ltd has released a press release.

View Attachment